Digital Equity for Stroke Approach
DESA
1 other identifier
interventional
80
1 country
1
Brief Summary
A community-academic partnership composed of a State University of New York (SUNY) Downstate Health Sciences University inter-disciplinary team of scientists (representing public health, medical informatics, vascular neurology/stroke center) and the Digital Equity Community Advisory Board (DECA) will guide our research. This is an NIH R21 pilot study. Our Specific Aims are designed to inform the sample design and research priorities for a larger NIH R01 experimental study and to serve as a platform for similar studies with other health conditions. We propose a mixed-methods study design with the following aims:
- 1.Assess and build setting, community, and user fit of DESA, leveraging qualitative methods and simulation telehealth encounters between the patient and neurologist.
- 2.Conduct a 9-month pilot randomized control trial (RCT) of DESA in a Central Brooklyn stroke population to examine the feasibility and preliminary efficacy. We will randomize 50 adults to DESA and 30 to usual care. The primary outcome will be BP control. Secondary outcomes include the number of BP measurements and medication compliance. Our primary hypothesis is that patients randomized to the DESA will significantly reduce systolic blood pressure at 9 months.
- 3.Examine barriers and facilitators to the adoption and integration of DESA into routine stroke care utilizing key informant interviews and user satisfaction surveys with neurologists and intervention participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2023
CompletedStudy Start
First participant enrolled
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedNovember 7, 2023
November 1, 2023
1 year
July 11, 2023
November 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure Change
Blood Pressure (Systolic and Diastolic) will be recorded by telehealth device daily
9 months
Secondary Outcomes (2)
Number of Blood Pressure readings/week
9 months
Medication Adherence
9 months
Study Arms (2)
Control
NO INTERVENTIONUsual Care
Intervention
EXPERIMENTALThe DESA Intervention will use a telehealth device to help the patient take blood pressure daily, and monitor blood pressure management.
Interventions
Intervention group is monitored via remote bp monitoring and telehealth device.
Eligibility Criteria
You may qualify if:
- African American or Afro-Caribbean
- years or over
- Experienced a stroke in the last 6 years
- A score between 2 and 4 on the Modified Rankin Scale2
- Has a formal or informal caregiver (e.g., relative, health aide or other) to assist them in activities of daily living
- Has a primary care physician at University Hospital of Brooklyn (UHB)
You may not qualify if:
- Mental illness (severe depression)
- dementia
- Non-English speakers
- aphasia
- severe dysarthria (slurred speech/impediment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital at Downstate
Brooklyn, New York, 11203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David R Kaufman, PhD, FACMI
SUNY Downstate Health Sciences University
- PRINCIPAL INVESTIGATOR
Aimee Afable, PhD, MPH
SUNY Downstate Health Sciences University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2023
First Posted
November 7, 2023
Study Start
October 17, 2023
Primary Completion
October 17, 2024
Study Completion
February 28, 2025
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share